Metal cations defibrillize the amyloid beta-protein fibrils

Neurochemical Research

Volumn 22, Issue 7, 1997, Pages 805-809

  Chauhan, Ved P S ^a   Ray, Indrani ^a   Chauhan, Abha ^a   Wegiel, Jerzy ^a   Wisniewski, Henryk M ^a  

^a NEW YORK STATE INSTITUTE FOR BASIC RESEARCH IN DEVELOPMENTAL DISABILITIES   (United States)

Author keywords

Alzheimer's disease; Amyloid beta protein; Defibrillization; Fibrillization; Metal cations

Indexed keywords

AMYLOID BETA PROTEIN; METAL ION;

ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; ELECTRON MICROSCOPY; FLUORESCENCE SPECTROSCOPY; HUMAN; NEUROCHEMISTRY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN STRUCTURE; STRUCTURE ANALYSIS;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; DRUG EVALUATION, PRECLINICAL; HUMANS; METALS; PEPTIDE FRAGMENTS; SOLUBILITY;

EID: 0030742959     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1022079709085     Document Type: Article

References (35)

1. 1-antichymotrypsin in the brain amyloid deposits of Alzheimer's disease. Cell 52:487-501.
2. Burdick, D., Soreghan, B., Kwon, M., Kosmoski, J., Knauer, M., Henschen, A., Yates, J., Cotman, C., and Glabe, C. 1992. Assembly and aggregation properties of synthetic Alzheimer's A4/beta amyloid peptide analogs. J. Biol. Chem. 267:546-554.
3. Bush, A. I., Pettingell, W. H., Multhaup, G., Paradis, M., Vonsaltel, J., Gusella, J. F., Beyreuther, K., Masters, C. L., and Tanzi, R. E. 1994. Rapid induction of Alzheimer Aβ amyloid formation by zinc. Science 265:1464-1467.
4. Chauhan, A., Chauhan, V. P. S., Rubenstein, R., Wegiel, J., and Wisniewski, H. M. 1997. Media from rhabdomyosarcoma and neuroblastoma cell cultures stimulate in vitro aggregation and fibrillization of amyloid beta-protein. Neurochem. Res. 22:227-232.
5. Chauhan, A., Chauhan, V. P. S., Wegiel, J., and Wisniewski, H. M. 1996. Impact of normal and heat-inactivated serum on in vitro aggregation and fibrillization of synthetic amyloid beta protein. Alzheimer's Res. 2:243-248.
6. Chauhan, A., Pirttila, T., Mehta, P., Chauhan, V. P. S., and Wisniewski, H. M. 1996. Effect of cerebrospinal fluid from normal and Alzheimer's patients with different apolipoprotein E phenotypes on in vitro aggregation of amyloid beta-protein. J. Neurol. Sci. 141:54-58.
7. Clements, A., Allsop, D., Walsh, D. M., and Williams, C. H. 1996. Aggregation and metal-binding properties of mutant forms of the amyloid - Aβ peptide of Alzheimer's disease. J. Neurochem. 66:740-747.
8. Constantinidis, J. 1992. Treatment of Alzheimer's Disease by zinc compounds. Drug Development Res. 27:1-14.
9. Coria, F., Castano, E. M., Prelli, F., Larrondo-Lillo, M., Van-Duinen, S., Shelanski, M. L., and Frangione, B. 1988. Isolation and characterization of amyloid P component from Alzheimer's disease and other type of cerebral amyloidosis. Lab. Invest. 58:454-457.
10. Exley, C., Price, N. C., Kelly, S. M., and Birchall, J. D. 1993. An interaction of β-amyloid with aluminum in vitro. FEBS Lett. 324:293-295.
11. Frieden, C. 1985. Actin and tubulin polymerization: the use of kinetic methods to determine mechanism. Ann. Rev. Biophys. Biophys. Chem. 14:189-210.
12. Haass, C., Schlossmacher, M. G., Hung, A. Y., Vigo-Pelfrey, C., Mellon, A., Ostaszewski, B. L., Lieberburg, I., Koo, E. H., Schenk, D., Teplow, D. B., and Selkoe, D. J. 1992. Amyloid beta-peptide is produced by cultured cells during normal metabolism. Nature 359:322-325.
13. Halverson, K., Fraser, P. E., Kirschner, D. A., and Lansburg, P. J. 1990. Molecular determinants of amyloid deposition in Alzheimer's disease: conformational studies of synthetic β-protein fragments. Biochemistry 29:2639-2644.
14. Hilbich, C., Kisters-Woike, B., Reed, J., Masters, C. L., and Beyreuther, K. 1991. Aggregation and secondary structure of synthetic amyloid βA4 peptides of Alzheimer's disease. J. Mol. Biol. 218:149-163.
15. Iwatsubo, T., Odaka, A., Suzuki, N., Mizusawa, H., Nukina, N., and Ihara, Y. 1994. Visualization of Aβ 42 (43) and Aβ 40 in senile plaques with end-specific Aβ monoclonals: Evidence that an initially deposited species is Aβ 42 (43). Neuron 13:45-53.
16. Jarett, J. T., and Lansbury, P. T. Jr. 1993. Seeding "One-Dimensional Crystallization" of amyloid: A pathogenic mechanism in Alzheimer's disease and scrapie? Cell 73:1055-1058.
17. Kida, E., Choi-Mura, N., and Wisniewski, K. E. 1995. Deposition of apolipoproteins E and J in senile plaques is topographically determined in both Alzheimer's disease and Down syndrome brain. Brain Res. 685:211-216.
18. Kirschner, D. A., Inouye, H., Duffy, L. K., Sinclair, A., Lind, M., and Selkoe, D. J. 1987. Synthetic peptide homologous to β-protein from Alzheimer's disease forms amyloid-like fibrils in vitro. Proc. Natl. Acad. Sci. U.S.A. 84:6953-6957.
19. LeVine, III, H. 1995. Soluble multimeric Alzheimer β (1-40) preamyloid complexes in dilute solution. Neurobiol. Aging 16:755-764.
20. Lorenzo, A., and Yanker, B. A. 1994. β-amyloid neurotoxicity requires fibril formation and is inhibited by congo red. Proc. Natl. Acad. Sci. U.S.A. 91:12243-12247.
21. Mantyh, P. W., Ghilardi, J. R., Rogers, S., DeMaster, E., Allen, C. J., Stimson, E. R., and Maggio, J. E. 1993. Aluminum, iron, and zinc ions promote aggregation of physiological concentrations of β-amyloid peptide. J. Neurochem. 61:1171-1174.
22. Masters, C. L., Simms, G., Weinman, N. A., Multhaup, G., McDonald, B. L., and Beyreuther, K. 1985. Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc. Natl. Acad. Sci. USA 82:4245-4249.
23. Miller, D. L., Papayannopoulos, I. A., Styles, J., Bobin, S. A., Lin, Y. Y., Biemann, L. K., and Iqbal, K. 1993. Peptide compositions of the cerebrovascular and senile plaque core amyloid deposits of Alzheimer disease. Arch. Biochem. Biophys. 301:41-52.
24. Pollard, T. D., and Cooper, J. A. 1986. Actin and actin-binding protein: A critical evaluation of mechanisms and functions. Ann. Rev. Biochem. 55:987-1035.
25. Roher, A. E., Lowenson, J. D., Clarke, S., Wolkow, C., Wang, R., Cotter, R. J., Reardon, I. M., Zurcher-Neely, H. A., Heinreikson, R. L., Ball, M. J., and Greenberg, B. D. 1993. Structural alteration in the peptide backbone of β-amyloid core protein may account for its deposition and stability in Alzheimer's disease. J. Biol. Chem. 268:3072-3083.
26. Seubert, P., Vigo-Pelfrey, C., Esch, F., Lee, M., Dovey, H., Davis, D., Sinha, S., Schlossmacher, M., Whaley, J., Swindelhyurst, C., McCormack R., Wolfert, R., Selkoe, D., Lieberburg, I., and Schenk, D. 1992. Isolation and quantitation of soluble Alzheimer's beta-peptide from biological fluids. Nature 359:325-327.
27. Simmons, L. K., May, P. C., Tomasseli, K. J., Rydel, R. E., Fuson, K. S., Brigham, E. F., Wright, S., Lieberburg, I., Becker, G. W., Brems, D. N., and Li, W. Y. 1994. Secondary structure of amyloid β-peptide correlates with neurotoxic activity in vitro. Mol. Pharmacol. 45:373-379.
28. Soto, C., Branes, M. C., Alvarez, J., and Inestrosa, N. C. 1994. Structural determinants of the Alzheimer's amyloid β-peptide. J. Neurochem. 63:1191-1198.
29. Su, J. H., Cummings, B. J., and Cotman, C. W. 1992. Localization of heparan sulfate glycosaminoglycan and proteoglycan core protein in aged brain and Alzheimer's disease. Neurosci. 51:801-813.
30. Vigo-Pelfrey, C., Lee, D., Keim, P., Lieberburg, I., and Schenk, D. B. 1993. Characterization of β-amyloid in peptide from human cerebrospinal fluid. J. Neurochem. 61:1965-1968.
31. Wegiel, J., Chauhan, A., Wisniewski, H. M., Nowakowski, J., Wang, K. C., and LeVine, III., H. 1996. Promotion of synthetic amyloid β-peptide fibrillization by culture media and cessation of fibrillization by serum. Neurosci. Lett. 211:151-154.
32. Wisniewski, T., Ghiso, J., and Frangione, B. 1994. Alzheimer's disease and soluble Aβ. Neurobiol. Aging 15:143-152.
33. Wisniewski, H. M., Frackowiak, J., and Mazur-Kolecka, B. 1995. In vitro production of β-amyloid in smooth muscle cells isolated from amyloid angiopathy-affected vessels. Neurosci. Lett. 183:120-123.
34. Wisniewski, H. M., Mehta, P. D., Kim, K. S., and Merz, G. S. 1989. Cerebrospinal fluid-based laboratory test for Alzheimer's disease. In: Boiler et al. (eds): Biological markers of Alzheimer's disease. Springer-Verlag, Berlin/Heidelberg pp. 23-29.
35. Wisniewski, H. M., Wegiel, J., and Kotula, L. 1996. Some neuropathology aspects of Alzheimer's disease and its relevance to other disciplines. Neuropathol. Appl. Neurobiol. 22:3-11.